American Gene Technologies International

American Gene Technologies® International Inc. (AGT™) is a private biotechnology company based in Rockville, Maryland. With 50 employees, AGT™ is focused on developing cures and treatments for a range of diseases. AGT™ specializes in gene and cell therapeutics, aiming to create innovative solutions for infectious diseases, cancers, and monogenic disorders. Their therapeutic programs include immunotherapy for HIV disease using gene-modified T cells, activation of innate T cell immunity for cancer treatment, and gene therapy for Phenylketonuria (PKU) by introducing a functional gene into cells with a dysfunctional gene. AGT™ has a robust lentiviral vector platform that enables them to rapidly adapt their gene delivery technology to various disease targets. The company's gene therapies are designed to provide clinical "cures" for complex diseases, and they hold numerous patents for their groundbreaking work. AGT™ is committed to collaborating with leading medical researchers globally to advance their research and bring effective treatments to patients. For more information or to contact American Gene Technologies® Inc., please visit their website at www.americangene.com/contact-us/.